[go: up one dir, main page]

GB2087721B - Injectable antibiotic formulations stabilised with glycofurol - Google Patents

Injectable antibiotic formulations stabilised with glycofurol

Info

Publication number
GB2087721B
GB2087721B GB8133767A GB8133767A GB2087721B GB 2087721 B GB2087721 B GB 2087721B GB 8133767 A GB8133767 A GB 8133767A GB 8133767 A GB8133767 A GB 8133767A GB 2087721 B GB2087721 B GB 2087721B
Authority
GB
United Kingdom
Prior art keywords
glycofurol
antibiotic formulations
injectable antibiotic
stabilised
formulations stabilised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8133767A
Other versions
GB2087721A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB8133767A priority Critical patent/GB2087721B/en
Publication of GB2087721A publication Critical patent/GB2087721A/en
Application granted granted Critical
Publication of GB2087721B publication Critical patent/GB2087721B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8133767A 1980-11-20 1981-11-09 Injectable antibiotic formulations stabilised with glycofurol Expired GB2087721B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8133767A GB2087721B (en) 1980-11-20 1981-11-09 Injectable antibiotic formulations stabilised with glycofurol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8037235 1980-11-20
GB8133767A GB2087721B (en) 1980-11-20 1981-11-09 Injectable antibiotic formulations stabilised with glycofurol

Publications (2)

Publication Number Publication Date
GB2087721A GB2087721A (en) 1982-06-03
GB2087721B true GB2087721B (en) 1984-01-25

Family

ID=26277580

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8133767A Expired GB2087721B (en) 1980-11-20 1981-11-09 Injectable antibiotic formulations stabilised with glycofurol

Country Status (1)

Country Link
GB (1) GB2087721B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321572D1 (en) * 2002-06-20 2008-07-24 Amnon Sintov TRANSDERMAL DRUG ADMINISTRATION SYSTEM
US9180088B2 (en) 2008-03-07 2015-11-10 Scidose, Llc Fulvestrant formulations
US11179468B2 (en) 2012-04-09 2021-11-23 Eagle Pharmaceuticals, Inc. Fulvestrant formulations

Also Published As

Publication number Publication date
GB2087721A (en) 1982-06-03

Similar Documents

Publication Publication Date Title
GB2109243B (en) Vacuum-compression injector
GB2132896B (en) Injector
GB2097187B (en) Electroluminescence structure
GB8333884D0 (en) Injector
GB8311561D0 (en) Taking up rod type materials
JPS57132888A (en) Antibiotic a-4696 factor group
IL63508A0 (en) Self-destructible syringes
GB2077731B (en) Macrolide antibiotics
GB2074787B (en) Electroluminescence structure
GB2113362B (en) Hollow charges
DE3067881D1 (en) Dual electron injector structures
DE3168693D1 (en) Macrolide antibiotics
GB2087721B (en) Injectable antibiotic formulations stabilised with glycofurol
JPS5758614A (en) Injectable drug composition
GB2089815B (en) Antibiotic a-4696 factor g
ZA816227B (en) 1-oxa-beta-lactam antibiotics
JPS5754591A (en) Antibiotics u-43120
GB8307570D0 (en) Organic materials
JPS55114799A (en) Injector for backkfilling
ZA813632B (en) Ampoule
GB2188351B (en) Grout stabilisation
AU7093881A (en) Stabilised petrol-alcohol blends
JPS57147466A (en) Injector
JPS5734072A (en) Basic refractories
PT76313B (en) Bacampicillin napsylate

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee